Latest news articles

Added 2 months ago Drug news

FDA approves sNDA of Cinvanti for nausea and vomiting from chemotherapy.- Heron Therapeutics

Heron Therapeutics announced that the FDA has approved Heron's supplemental New Drug Application (sNDA) for Cinvanti (aprepitant) injectable emulsion for...

Added 10 months ago Drug news

Injectable emulsion for prevention of acute and delayed nausea and vomiting approved

FDA approves expanded indication for Cinvanti in nausea and vomiting

Added 1 year ago Drug news

Phase III study of Barhemsys as rescue treatment of post-operative nausea & vomiting (PONV) has been published in Anesthesiology.- Acacia Pharma

Acacia Pharma Group plc announced that data and analyses from its positive Phase III clinical trial of Barhemsys (intravenous amisulpride)...

Search all news articles for Nausea and vomiting
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Fluid Management

Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

+ 2 more

Hereditary ATTR amyloidosis

Hereditary ATTR amyloidosis

Explore the pathophysiology, epidemiology and multi-system symptoms associated with hereditary ATTR amyloidosis, as well as how to achieve an early and accurate diagnosis.

Load more

Guidelines

Cannabis-based medicinal products

This guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.

Added 1 month ago

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

The guidelines on antiemetics provide an update on the classification of the emetogenic potential of antineoplastic agents, adding 42 new drugs many of which are orally administered. The recommendations for the prophylaxis of nausea and vomiting...

Added 9 years ago

Diarrhoea and vomiting caused by gastroenteritis in under 5s: diagnosis and management

This guideline applies to children younger than 5 years who present to a healthcare professional for advice in any setting.

Added 10 years ago

Search all guidelines for Nausea and vomiting
 

Journal articles

Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations.

Knowledge of the involvement of the neurokinin substance P in emesis has led to the development of the neurokinin-1 receptor antagonists (NK-1 RAs) for control of chemotherapy-induced nausea and vomiting (CINV)...

Added 2 years ago

Rolapitant: A Review in Chemotherapy-Induced Nausea and Vomiting.

Oral rolapitant (Varubi™; Varuby®), a long-acting neurokinin-1 (NK1) receptor antagonist (RA), is indicated in the USA and EU as part of an antiemetic regimen to prevent delayed chemotherapy-induced nausea and vomiting (CINV)...

Added 2 years ago

Clinical pharmacology of neurokinin-1 receptor antagonists for the treatment of nausea and vomiting associated with chemotherapy.

Introduction: Five NK-1 RA formulations are commercially available to treat the delayed phase of chemotherapy-induced nausea and vomiting (CINV) occurring between days 2–5 post chemotherapy...

Added 2 years ago

Search all journal articles for Nausea and vomiting
 

CME

Vomiting in adults - red flag symptoms

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
0
Registration required
1
Subscription fee
0

Vomiting in children - red flag symptoms

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
0
Registration required
1
Subscription fee
0

Cyclical vomiting syndrome: diagnosis and management

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
0
Search all CME for Nausea and vomiting